Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bogaards, Johannes A
Smith, Megan A
Chesson, Harrell W
Burger, Emily A
Choi, Yoon H
De Blasio, Birgitte Freiesleben
De Vlas, Sake J
Hontelez, Jan A C
Jepsen, Martin R
Kim, Jane J
Matthijsse, Suzette M
Mikolajczyk, Rafael T
Shafer, Leigh Anne
Tully, Stephen P
Turner, Hugo C
MetadataShow full item record
AbstractModelling studies have been widely used to inform human papillomavirus (HPV) vaccination policy decisions; however, many models exist and it is not known whether they produce consistent predictions of population-level effectiveness and herd effects. We did a systematic review and meta-analysis of model predictions of the long-term population-level effectiveness of vaccination against HPV 16, 18, 6, and 11 infection in women and men, to examine the variability in predicted herd effects, incremental benefit of vaccinating boys, and potential for HPV-vaccine-type elimination.
CitationPopulation-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. 2016, 1 (1):e8-e17 Lancet Public Health
AffiliationHelmholtz Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
JournalThe Lancet. Public health
The following license files are associated with this item:
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
- Authors: Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M
- Issue date: 2015 May
- Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.
- Authors: Lehtinen M, Apter D, Baussano I, Eriksson T, Natunen K, Paavonen J, Vänskä S, Bi D, David MP, Datta S, Struyf F, Jenkins D, Pukkala E, Garnett G, Dubin G
- Issue date: 2015 Mar 3
- The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis.
- Authors: Malagón T, Joumier V, Boily MC, Van de Velde N, Drolet M, Brisson M
- Issue date: 2013 Mar 25
- Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
- Authors: Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J
- Issue date: 2013 Jan 8
- Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.
- Authors: Regan DG, Philp DJ, Hocking JS, Law MG
- Issue date: 2007 Sep